Kaoru Takagi
Overview
Explore the profile of Kaoru Takagi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saito K, Nakai Y, Sasaki T, Takeda T, Ueno M, Tezuka S, et al.
Pancreas
. 2025 Feb;
54(2):e107-e113.
PMID: 39928888
Purpose: The aim of this multicenter retrospective study was to evaluate the impact of statin use on clinical outcomes in patients with unresectable pancreatic cancer (PC) receiving gemcitabine plus nab-paclitaxel...
2.
Oyama H, Hamada T, Nakai Y, Tanaka M, Takagi K, Fukuda R, et al.
Ann Surg
. 2024 Mar;
PMID: 38506039
Objective: To examine whether long-term surveillance of intraductal papillary mucinous neoplasms (IPMNs) leads to early diagnosis and better clinical outcomes of pancreatic ductal adenocarcinomas (PDACs) developing concomitantly with IPMNs. Summary...
3.
Hamada T, Oyama H, Nakai Y, Tada M, Koh H, Tateishi K, et al.
Cancer Epidemiol Biomarkers Prev
. 2021 Mar;
30(5):1020-1028.
PMID: 33653811
Background: ABO blood group has been associated with risks of various malignancies, including pancreatic cancer. No study has evaluated the association of ABO blood group with incidence of pancreatic carcinogenesis...
4.
Arai J, Kato J, Toda N, Kurokawa K, Shibata C, Kurosaki S, et al.
BMC Gastroenterol
. 2021 Jan;
21(1):16.
PMID: 33407172
Background: Impairment of activities of daily living (ADL) due to hemorrhagic gastroduodenal ulcers (HGU) has rarely been evaluated. We analyzed the risk factors of poor prognosis, including mortality and impairment...
5.
Arai J, Kato J, Toda N, Kurokawa K, Shibata C, Kurosaki S, et al.
Clin J Gastroenterol
. 2020 Sep;
14(1):391.
PMID: 32949332
No abstract available.
6.
Arai J, Kato J, Toda N, Kurokawa K, Shibata C, Kurosaki S, et al.
Clin J Gastroenterol
. 2020 Aug;
14(1):314-318.
PMID: 32779145
Intraductal papillary mucinous neoplasm of the bile duct (IPNB) is an epithelial tumor that can cause obstructive jaundice and cholangitis due to mucin production. Although the effectiveness of argon plasma...
7.
Kurokawa K, Ohki T, Kato J, Fukumura Y, Imai M, Shibata C, et al.
J Med Case Rep
. 2020 May;
14(1):62.
PMID: 32456712
Background: Combination therapy of interferon and ribavirin has traditionally been used to eradicate hepatitis C virus. The sustained virologic response achieved with interferon-related therapy is persistent, and late relapses after...
8.
Oyama H, Tada M, Takagi K, Tateishi K, Hamada T, Nakai Y, et al.
Gastroenterology
. 2019 Sep;
158(1):226-237.e5.
PMID: 31473224
Background & Aims: Long-term outcomes of patients with branch-duct intraductal papillary mucinous neoplasms (IPMNs), particularly those after 5 years of surveillance, have not been fully evaluated in large studies. We...
9.
Shibata C, Kato J, Toda N, Imai M, Fukumura Y, Arai J, et al.
J Med Case Rep
. 2019 Jun;
13(1):168.
PMID: 31153385
Background: While dermatomyositis is often associated with malignancy, several autoimmune diseases like myositis can be caused by immune checkpoint inhibitors. Differentially diagnosing malignancy-associated dermatomyositis or myositis caused by immune checkpoint...
10.
Saito T, Nakai Y, Isayama H, Hirano K, Ishigaki K, Hakuta R, et al.
Pancreas
. 2018 Jun;
47(7):800-806.
PMID: 29851751
Objective: Exocrine pancreatic insufficiency may impair the nutritional status in pancreatic cancer (PC), but the role of pancreatic enzyme replacement therapy (PERT) is not fully evaluated. Therefore, we conducted this...